Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.

about

Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer

P2860

Q58093819-2342E412-AED3-47FA-91B8-6AE8DEB9581F

P2860

Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.

Item

http://www.wikidata.org/entity/Q42099922

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.

@en

Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.

@nl

type

Item

label

Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.

@en

Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.

@nl

prefLabel

Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.

@en

Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.

@nl

P1476

Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments

@en

P2093

Giovanni Scambia

http://www.w3.org/2001/XMLSchema#string

Giuseppe Colloca

http://www.w3.org/2001/XMLSchema#string

Giuseppe Vizzielli

http://www.w3.org/2001/XMLSchema#string

William C Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

The role of immune checkpoint inhibition in the treatment of ovarian cancer

Frailty in older adults: evidence for a phenotype

Cancer statistics, 2016

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

Physical performance measures for predicting outcome in cancer patients: a systematic review.

Frailty: an outcome predictor for elderly gynecologic oncology patients.

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.

Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer

Frailty in elderly people

P304

677-684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14336/AD.2017.0607

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Domenico Fusco

R Bernabei

Lucia Tortorella

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28966809

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5614329

http://www.w3.org/2001/XMLSchema#string

Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.

about

P2860

P2860

Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932